IDH1 and breast cancer: Future studies are required to resolve these issues, but we have also analyzed glutamine dependency in a panel of BCR-ABL+ CP-CML and BC-CML patient samples, as well as in an IDH1 R132H-mutant AML sample where this erythroid skewing was not observed.